As of November 2024, Catalyst Pharmaceuticals has a market cap of $2.40B. This makes Catalyst Pharmaceuticals the world's 4622th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.62B | -18.23% |
2023 | $1.98B | -9.62% |
2022 | $2.19B | 174.74% |
2021 | $795.92M | 102.69% |
2020 | $392.67M | -10.93% |
2019 | $440.87M | 95.31% |
2018 | $225.72M | -50.90% |
2017 | $459.68M | 272.38% |
2016 | $123.44M | -57.14% |
2015 | $288.03M | -17.51% |
2014 | $349.17M | 52.31% |
2013 | $229.25M | 343.18% |
2012 | $51.73M | -65.89% |
2011 | $151.66M | 30.30% |
2010 | $116.39M | 57.14% |
2009 | $74.07M | -65.00% |
2008 | $211.62M | -47.83% |
2007 | $405.60M | -28.57% |
2006 | $567.84M | - |